Related Experiment Video
Updated: Apr 27, 2026

Detection of Protease Activity by Fluorescent Peptide Zymography
Published on: January 20, 2019
Prion fragment peptides are digested with membrane type matrix metalloproteinases and acquire enzyme resistance
Aya Kojima1, Motomi Konishi2, Toshifumi Akizawa3
1Analytical Chemistry, Pharmaceutical Science, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan. ayak@ims.u-tokyo.ac.jp.
Abstract:
Prions are the cause of neurodegenerative disease in humans and other mammals. The structural conversion of the prion protein (PrP) from a normal cellular protein (PrPC) to a protease-resistant isoform (PrPSc) is thought to relate to Cu2+ binding to histidine residues. In this study, we focused on the membrane-type matrix metalloproteinases (MT-MMPs) such as MT1-MMP and MT3-MMP, which are expressed in the brain as PrPC-degrading proteases. We synthesized 21 prion fragment peptides. Each purified peptide was individually incubated with recombinant MT1-MMP or MT3-MMP in the presence or absence of Cu2+ and the cleavage sites determined by LC-ESI-MS analysis. Recombinant MMP-7 and human serum (HS) were also tested as control. hPrP61-90, from the octapeptide-repeat region, was cleaved by HS but not by the MMPs tested here. On the other hand, hPrP92-168 from the central region was cleaved by MT1-MMP and MT3-MMP at various sites. These cleavages were inhibited by treatment with Cu2+. The C-terminal peptides had higher resistance than the central region. The data obtained from this study suggest that MT-MMPs expressed in the brain might possess PrPC-degrading activity.
Insights
Matrix metalloproteinases (MT-MMPs) in the brain may degrade the prion protein (PrPC). Copper ions (Cu2+) inhibited this degradation, suggesting a role in prion disease mechanisms.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Prions cause fatal neurodegenerative diseases by misfolding the prion protein (PrP).
- Copper (Cu2+) binding to histidine residues is implicated in PrP structural conversion.
- Membrane-type matrix metalloproteinases (MT-MMPs), including MT1-MMP and MT3-MMP, are brain proteases.
Purpose of the Study:
- To investigate the potential of brain-expressed MT-MMPs to degrade the normal cellular prion protein (PrPC).
- To determine the effect of Cu2+ on MT-MMP-mediated PrP cleavage.
Main Methods:
- Synthesis and purification of 21 prion fragment peptides.
- Incubation of peptides with recombinant MT1-MMP or MT3-MMP, with or without Cu2+.
- Analysis of cleavage sites using Liquid Chromatography-Electrospray Ionization Mass Spectrometry (LC-ESI-MS).
Main Results:
- MT1-MMP and MT3-MMP cleaved the central region of human PrP (hPrP92-168) at multiple sites.
- Cu2+ inhibited the cleavage activity of MT-MMPs on PrP peptides.
- Prion peptides from the C-terminal region exhibited greater resistance to cleavage than those from the central region.
Conclusions:
- Brain-expressed MT-MMPs possess PrPC-degrading activity.
- Cu2+ may play a regulatory role in MT-MMP-mediated PrPC degradation.
- These findings offer insights into the biochemical pathways involved in prion pathogenesis.
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Protein Digestion
Mitochondrial Precursor Proteins
Most of the mitochondrial...
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Role of Matrix Metalloproteases in Degradation of ECM

